Trial Information
Inclusion Criteria:
- ECOG performance status 0-2 at the time of inclusion
- Following R0 or R1 pancreatic tubular adenocarcinoma resection and adjuvant
gemcitabine treatment
Exclusion Criteria:
- Pregnancy
- Less than 3 mths expected survival
- Serious comorbidity
- Age above 70 yrs
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
PROGRESSION FREE SURVIVAL
Outcome Time Frame:
1 YEAR
Safety Issue:
No
Authority:
Slovenia: Agency for Medicinal Products and Medical Devices of the Republic of Slovenia
Study ID:
MIS
NCT ID:
NCT01021800
Start Date:
April 2009
Completion Date:
December 2012
Related Keywords:
- Pancreatic Tubular Adenocarcinoma
- Pancreatic tubular adenocarcinoma adjuvant setting
- Adenocarcinoma
- Adenocarcinoma, Mucinous